Ticker: VRTX

Company: VERTEX PHARMACEUTICALS INC / MA

Person: Reshma Kewalramani, director, officer

Transaction date: July 30, 2024

Reporting date: Aug. 1, 2024

Average share price: 505.0

Sold 15202.0 shares for 7677010.0